journal article·2015-04-24Open access

Using Magnetic Nanoparticles for Gene Transfer to Neural Stem Cells: Stem Cell Propagation Method Influences Outcomes

Mark Pickard, Christopher Adams, Perrine Barraud, Divya Chari

Abstract

Genetically engineered neural stem cell (NSC) transplants offer a key strategy to augment neural repair by releasing therapeutic biomolecules into injury sites. Genetic modification of NSCs is heavily reliant on viral vectors but cytotoxic effects have prompted development of non-viral alternatives, such as magnetic nanoparticle (MNPs). NSCs are propagated in laboratories as either 3-D suspension “neurospheres” or 2-D adherent “monolayers”. MNPs deployed with oscillating magnetic fields (“magnetofection technology”) mediate effective gene transfer to neurospheres but the efficacy of this approach for monolayers is unknown. It is important to address this issue as oscillating magnetic fields dramatically enhance MNP-based transfection in transplant cells (e.g., astrocytes and oligodendrocyte precursors) propagated as monolayers. We report for the first time that oscillating magnetic fields enhanced MNP-based transfection with reporter and functional (basic fibroblast growth factor; FGF2) genes in monolayer cultures yielding high transfection versus neurospheres. Transfected NSCs showed high viability and could re-form neurospheres, which is important as neurospheres yield higher post-transplantation viability versus monolayer cells. Our results demonstrate that the combination of oscillating magnetic fields and a monolayer format yields the highest efficacy for MNP-mediated gene transfer to NSCs, offering a viable non-viral alternative for genetic modification of this important neural cell transplant population.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Graphene and Nanomaterials Applications · Pluripotent Stem Cells Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cellular and Neural Engineering Group, Institute for Science and Technology in Medicine, Keele University, Keele, Staffordshire ST5 5BG, UK

Department of Physiology, Development and Neuroscience, University of Cambridge, Anatomy Building, Downing Street, Cambridge CB2 3DY, UK

Funding

BBSRC · EPSRC

References (39)

Show source-provided references
1. Stem cell-based cell therapy in neurological diseases: A review10.1002/jnr.22054 ↗
2. Neural stem cell-mediated therapy for rare brain diseases: Perspectives in the near future for LSDs and MNDs
3. Stem cells in human neurodegenerative disorders—Time for clinical translation?10.1172/JCI40543 ↗
4. Trounson, A., Thakar, R.G., Lomax, G., and Gibbons, D. (2011). Clinical trials for stem cell therapies. BMC Med., 9.10.1186/1741-7015-9-52 ↗
5. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson’s disease: Five-year post-operative outcome10.2174/1876893800901010020 ↗
6. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model10.1073/pnas.022438099 ↗
7. Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction10.2217/rme.10.103 ↗
8. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type VII mouse10.1002/jnr.10764 ↗
9. Genetic modification of stem cells for transplantation10.1016/j.addr.2007.08.035 ↗
10. Retroviral vectors for gene delivery to neural precursor cells10.1016/S0074-7742(03)01005-5 ↗
11. Genetic modification of neural stem cells10.1038/sj.mt.6300402 ↗
12. Gene delivery to adult neural stem cells10.1006/excr.2002.5569 ↗
13. Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors10.1038/sj.gt.3301646 ↗
14. Adult neural stem and progenitor cells modified to secrete GDNF can protect, migrate and integrate after intracerebral transplantation in rats with transient forebrain ischemia10.1111/j.1460-9568.2007.05776.x ↗
15. Non-viral gene transfer by nucleofection allows stable gene expression in human neural progenitor cells10.1016/j.jneumeth.2008.11.007 ↗
16. Nonviral vectors for gene delivery10.1021/cr800409e ↗
17. Non-viral nucleic acid delivery: Key challenges and future directions10.2174/156720111795256174 ↗
18. Magnetic nanoparticle-mediated gene transfer to oligodendrocyte precursor cell transplant populations is enhanced by magnetofection strategies10.1021/nn2018717 ↗
19. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by “magnetofection”: Effects of static and oscillating fields10.2217/nnm.09.109 ↗
20. The transfection of multipotent neural precursor/stem cell transplant populations with magnetic nanoparticles10.1016/j.biomaterials.2010.12.007 ↗
21. Magnetically enhanced nucleic acid delivery10.1016/j.addr.2011.08.002 ↗
22. High transfection efficiency of neural stem cells with magnetofection10.2144/000113628 ↗
23. Magnetic nanoparticle mediated transfection of neural stem cell suspension cultures is enhanced by applied oscillating magnetic fields10.1016/j.nano.2013.05.014 ↗
24. Magnetic nanoparticles for gene and drug delivery
25. Nucleofection is the most efficient nonviral transfection method for neuronal stem cells derived from ventral mesencephali with no changes in cell composition or dopaminergic fate10.1634/stemcells.2006-0176 ↗
26. Nonviral gene delivery in neural progenitors derived from human pluripotent stem cells10.1007/978-1-61779-201-4_25 ↗
27. Differences in magnetic particle uptake by CNS neuroglial subclasses: Implications for neural tissue engineering10.2217/nnm.12.145 ↗
28. Neurospheres: Insights into neural stem cell biology10.1002/jnr.20333 ↗
29. Long-term culture and neuronal survival after intraspinal transplantation of human spinal cord-derived neurospheres10.1016/j.physbeh.2007.05.056 ↗
30. Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord10.3727/096368908786516756 ↗
31. Neural stem cell gene therapy ameliorates pathology and function in a mouse model of globoid cell leukodystrophy10.1002/stem.701 ↗
32. Lentivirus-mediated expression of insulin-like growth factor-I promotes neural stem/precursor cell proliferation and enhances their potential to generate neurons10.1111/j.1471-4159.2010.06939.x ↗
33. Retrovirus delivered neurotrophin-3 promotes survival, proliferation and neuronal differentiation of human fetal neural stem cells in vitro10.1016/j.brainresbull.2008.02.037 ↗
34. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury10.1016/j.expneurol.2006.03.016 ↗
35. Genetic therapy for the nervous system10.1093/hmg/ddr110 ↗
36. Co-transfection with cDNA encoding the Bcl family of anti-apoptotic proteins improves the efficiency of transfection in primary fetal neural stem cells10.1016/S0165-0270(02)00090-0 ↗
37. Efficient non-viral transfection of adult neural stem/progenitor cells, without affecting viability, proliferation or differentiation10.1002/jgm.823 ↗
38. Plasmid-mediated gene therapy for cardiovascular disease10.1093/cvr/cvr197 ↗
39. Multifunctional magnetic nanoparticles for medical imaging applications10.1039/b902182e ↗